– SWEDEN, Stockholm – EnginZyme, the cell-free synthetic biology company, today announced a €6.4 million Series A investment led by Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, bringing the total funding to over €10 million since 2014.…
– ISRAEL, Rehovot – Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, today announced it has closed a $27 million round of financing led by Sofinnova Partners, a leading European life sciences venture capital firm, and joined by Professor Jacques Seguin, Chairman of the company, with further participation from existing investors.…
– USA, CA – Nitrome Biosciences, a privately-held biopharmaceutical company developing a platform around a newly identified class of enzymes to target Parkinson’s disease and other age-related disorders, today announced that it has closed a Series A financing of $38 million co-led by Sofinnova Partners and AbbVie Ventures, with further participation from the Dementia Discovery Fund, Mission Bay Capital and Alexandria Venture Investments.…
-FRANCE, Baillargues – Microphyt, a leading company in microalgae-based natural solutions for nutrition and well-being, announced fundraising of €28.5 million.…
– FRANCE, Paris – AblaCare, a medical device company dedicated to transforming women’s health and fertility care, today announced that it has raised €10 million in Series A financing from Sofinnova Partners.…